About MedReleaf (TSE:LEAF)
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
SymbolTSE:LEAF
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-21.65%
Return on Equity-6.38%
Return on Assets-5.47%
Miscellaneous
EmployeesN/A
Outstanding Shares99,145,000
MedReleaf (TSE:LEAF) Frequently Asked Questions
What is MedReleaf's stock symbol?
MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF."
What price target have analysts set for LEAF?
2 brokers have issued 1 year target prices for MedReleaf's stock. Their predictions range from C$20.00 to C$36.00. On average, they expect MedReleaf's stock price to reach C$28.67 in the next twelve months. View Analyst Ratings for MedReleaf.
Who are some of MedReleaf's key competitors?
Some companies that are related to MedReleaf include Abcam (ABCZY), Aurora Cannabis (ACBFF), GW Pharmaceuticals (GWPH), Neogen (NEOG), Advanced Accelerator Application (AAAP), Blueprint Medicines (BPMC), Ligand Pharmaceuticals (LGND), BTG (BTGGF), Enerplus (ERF), Acadia Healthcare (ACHC), Amn Healthcare Services (AMN), UDG Healthcare (UDHCF), Spark Therapeutics (ONCE), Inogen (INGN), Indivior (INDV), Array BioPharma (ARRY), arGEN-X BV (ARGX) and China Biologic Products (CBPO).
Who are MedReleaf's key executives?
MedReleaf's management team includes the folowing people:
- Mr. Neil J. Closner, CEO & Director
- Mr. Igor Gimelshtein, CFO & Corp. Sec.
- Mr. Donald Courtney, Chief Operating Officer
- Mr. Angelo Fefekos, Vice-Pres of Clinical Affairs & Quality Compliance
- Mr. Darren Karasiuk, Vice-Pres of Strategy
Has MedReleaf been receiving favorable news coverage?
Media stories about LEAF stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. MedReleaf earned a media sentiment score of 0.14 on Accern's scale. They also assigned news stories about the company an impact score of 45.91 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of MedReleaf?
Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is MedReleaf's stock price today?
One share of LEAF stock can currently be purchased for approximately C$19.69.
How big of a company is MedReleaf?
MedReleaf has a market capitalization of C$1.91 billion.
MarketBeat Community Rating for MedReleaf (LEAF)
MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe LEAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LEAF will underperform the S&P 500 over the long term. You may vote once every thirty days.
MedReleaf (TSE:LEAF) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for MedReleaf in the last 12 months. Their average twelve-month price target is C$28.67, suggesting that the stock has a possible upside of 45.59%. The high price target for LEAF is C$36.00 and the low price target for LEAF is C$20.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 2.50 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | C$28.67 | C$28.67 | C$25.33 | C$13.00 |
| Price Target Upside: | 45.59% upside | 36.05% upside | 6.86% downside | 41.15% upside |
MedReleaf (TSE:LEAF) Consensus Price Target History
MedReleaf (TSE:LEAF) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 2/14/2018 | Canaccord Genuity | Boost Price Target | Buy | C$21.50 -> C$30.00 |  |
| 1/8/2018 | Cowen | Boost Price Target | | C$20.00 -> C$36.00 | |
| 11/15/2017 | Eight Capital | Boost Price Target | Buy | C$13.00 -> C$20.00 | |
(Data available from 4/23/2016 forward)
MedReleaf (TSE:LEAF) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
MedReleaf (TSE LEAF) Insider Trading and Institutional Ownership History
MedReleaf (TSE LEAF) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/13/2018 | Ray Leach | Insider | Sell | 100,000 | C$19.40 | C$1,940,000.00 | | |
| 4/6/2018 | Ray Leach | Insider | Sell | 41,500 | C$15.40 | C$639,100.00 | | |
| 3/27/2018 | Eitan Popper | Insider | Buy | 27,500 | C$18.09 | C$497,475.00 | | |
| 3/7/2018 | Ray Leach | Insider | Sell | 100,000 | C$19.75 | C$1,975,000.00 | | |
| 3/1/2018 | Ray Leach | Insider | Sell | 77,800 | C$20.04 | C$1,559,112.00 | | |
| 2/27/2018 | Ray Leach | Insider | Sell | 19,600 | C$19.00 | C$372,400.00 | | |
| 2/9/2018 | Stephen Arbib | Insider | Sell | 36,600 | C$18.01 | C$659,166.00 | | |
| 2/6/2018 | Stephen Arbib | Insider | Sell | 50,600 | C$18.00 | C$910,800.00 | | |
| 1/29/2018 | Olam Ltd. Tikun | Insider | Sell | 1,000,000 | C$22.02 | C$22,020,000.00 | | |
| 1/25/2018 | Olam Ltd. Tikun | Insider | Sell | 28,600 | C$25.00 | C$715,000.00 | | |
| 1/23/2018 | Olam Ltd. Tikun | Insider | Sell | 29,300 | C$25.00 | C$732,500.00 | | |
| 8/24/2017 | Stephen Arbib | Insider | Sell | 100 | C$8.10 | C$810.00 | | |
| 8/23/2017 | Stephen Arbib | Insider | Sell | 10,000 | C$8.10 | C$81,000.00 | | |
| 6/8/2017 | Stephen Arbib | Insider | Buy | 800 | C$7.89 | C$6,312.00 | | |
(Data available from 1/1/2013 forward)
MedReleaf (TSE LEAF) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Global Cannabis Pioneer Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership to Deliver Science-Backed Cannabis Products to PA MMJ Patients
finance.yahoo.com - April 17 at 10:31 AM |
 | Ray Leach Sells 100,000 Shares of MedReleaf (LEAF) Stock
www.americanbankingnews.com - April 13 at 7:09 PM |
 | Better Buy to Beat the TSX: Canada Goose Holdings Inc. or MedReleaf Corp.?
www.fool.ca - April 13 at 3:21 PM |
 | Marijuana firms use creative marketing tactics to skirt strict regulations
www.theglobeandmail.com - April 12 at 3:23 PM |
| MedReleaf completes 164 acre property and 1 million square foot greenhouse acquisition
finance.yahoo.com - April 12 at 3:23 PM |
| Is MedReleaf Corp’s (TSE:LEAF) Balance Sheet A Threat To Its Future?
finance.yahoo.com - April 11 at 5:34 AM |
| MedReleaf (LEAF) Insider Sells C$639,100.00 in Stock
www.americanbankingnews.com - April 10 at 4:16 PM |
| This Marijuana Stock Is Working Smarter, Not Harder
www.fool.com - April 10 at 3:16 PM |
| MedReleaf announces senior leadership team additions bringing depth and experience from the global pharmaceutical industry
finance.yahoo.com - April 6 at 3:23 PM |
 | Marijuana Millionaires Ride Canada's Legalization Wave
www.bloomberg.com - April 5 at 3:20 PM |
| MedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in Mind
finance.yahoo.com - April 3 at 7:40 AM |
| Canaccord Genuity Reiterates C$15.00 Price Target for MedReleaf (LEAF)
www.americanbankingnews.com - April 1 at 10:52 PM |
| Marijuana marketing: The race to stand out
www.theglobeandmail.com - March 31 at 6:33 AM |
 | Marijuana Stocks Could Be a Buzzkill
www.barrons.com - March 30 at 3:18 PM |
| MedReleaf (LEAF) Insider Purchases C$497,475.00 in Stock
www.americanbankingnews.com - March 29 at 1:52 PM |
 | Worldwide Spending in the Legal Cannabis Market is Set to Grow
www.bizjournals.com - March 28 at 3:13 PM |
| MedReleaf signs supply agreement with Cannamedical Pharma GmbH in Germany
finance.yahoo.com - March 19 at 3:22 PM |
 | Data Projects What Cannabis Market Could Look Like Under Full Federal Legalization - PR Newswire (press release)
www.prnewswire.com - March 16 at 3:17 PM |
| Ray Leach Sells 100,000 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - March 12 at 2:02 PM |
| 5 Marijuana Stocks With the Highest Production Capacity - Motley Fool
www.fool.com - March 9 at 3:24 PM |
| Marijuana Stocks That Do This Will Probably Be the Most Profitable ... - Motley Fool
www.fool.com - March 7 at 5:30 AM |
| MedReleaf adds the iconic Woodstock brand to its recreational market portfolio
finance.yahoo.com - March 6 at 8:26 AM |
| Ray Leach Sells 19,600 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - March 4 at 12:10 AM |
| MedReleaf Corp (LEAF) Insider Sells C$1,559,112.00 in Stock
www.americanbankingnews.com - March 4 at 12:10 AM |
| MedReleaf to purchase 164 acre property, including 1 million square feet of existing greenhouse to add an additional 105,000 kg of fully funded capacity output
finance.yahoo.com - February 26 at 7:15 AM |
| MedReleaf Corp. Returns to Growth — and Potential Acquisitions - The Motley Fool Canada
www.fool.ca - February 16 at 3:18 PM |
 | Pot Pharm: Booming Canada weed sector plots next-wave medicines
www.reuters.com - February 16 at 6:31 AM |
| Pot Pharm - Booming Canada weed sector plots next-wave medicines
finance.yahoo.com - February 16 at 6:31 AM |
| Recreational marijuana sales in Canada face fresh delays
finance.yahoo.com - February 16 at 6:31 AM |
| MedReleaf (LEAF) PT Raised to C$30.00
www.americanbankingnews.com - February 14 at 3:12 PM |
| MedReleaf Reports Third Quarter Fiscal 2018 Results
finance.yahoo.com - February 13 at 3:15 PM |
| MedReleaf Corp (LEAF) Insider Sells C$659,166.00 in Stock
www.americanbankingnews.com - February 12 at 6:30 PM |
| MedReleaf Corp. Launches Recreational Cannabis Brand: San Rafael '71 - The Motley Fool Canada
www.fool.ca - February 12 at 3:15 PM |
| Stephen Arbib Sells 50,600 Shares of MedReleaf Corp (LEAF) Stock
www.americanbankingnews.com - February 9 at 3:30 PM |
| MedReleaf introduces first adult-use recreational cannabis brand: San Rafael '71 launches with cannabis-inspired beer
finance.yahoo.com - February 9 at 3:15 PM |
| Marijuana can only go on sale in Canada months after law passed -minister
finance.yahoo.com - February 7 at 5:15 AM |
| MedReleaf receives Health Canada approval for cannabis oil softgel capsules
finance.yahoo.com - February 6 at 3:15 PM |
| MedReleaf Corp. Announces Closing of Previously Announced Offering
finance.yahoo.com - January 31 at 3:15 PM |
| Insider Selling: MedReleaf Corp (LEAF) Insider Sells 1,000,000 Shares of Stock
www.americanbankingnews.com - January 30 at 3:12 PM |
| Tikun Olam Announces Holdings in MedReleaf Corporation
finance.yahoo.com - January 30 at 3:11 PM |
| MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 28,600 Shares
www.americanbankingnews.com - January 29 at 3:14 PM |
| MedReleaf Corp. to Host Third Quarter Fiscal 2018 Conference Call
finance.yahoo.com - January 29 at 3:13 PM |
| Cannabis Stocks Begin To Reflect The Real Industry
finance.yahoo.com - January 28 at 3:15 PM |
| Better Marijuana Stock: Aphria vs. MedReleaf -- The Motley Fool - Motley Fool
www.fool.com - January 28 at 5:16 AM |
| MedReleaf Corp (LEAF) Insider Olam Ltd. Tikun Sells 29,300 Shares
www.americanbankingnews.com - January 25 at 9:28 PM |
| Make it or Break it: Here are 3 of the Most Exciting Stocks Available Today
www.fool.ca - January 25 at 3:12 PM |
| BMO Open to More Pot Deals If Firms Pass Bank's Tests, CEO Says - Bloomberg
www.bloomberg.com - January 25 at 3:12 PM |
 | Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling - Benzinga
www.benzinga.com - January 25 at 5:15 AM |
| It's High Times for Pot Deals in Canada Ahead of Legalization - Bloomberg
www.bloomberg.com - January 24 at 3:15 PM |
 | MedReleaf Ready To Rumble: Positioned Well For Long-Term Growth - Seeking Alpha
seekingalpha.com - January 23 at 3:17 PM |
MedReleaf (TSE:LEAF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
MedReleaf (TSE LEAF) Stock Chart for Monday, April, 23, 2018
Loading chart…
